1-(3,4-DIFLUOROPHENYL)-3-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)UREA, 95%, 250mg

N'-(4,6-dimethyl-1,3-benzothiazol-2-yl)-N,N-dimethylethane-1,2-diamine, 95.0%, 500mg

3-Methylcyclohexanol (cis- and trans- mixture)>98.0%(GC)25mL

2-Hydroxy-4-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 98%, 250mg

Ethyl 2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methylthiazole-5-carboxylate, 95+%, 500mg

Acetonitrile D3, 99.8 at%D, 25 ml, glass packaging

Bismuth(III) Iodide Anhydrous>98.0%(T)25g

(4-Hydroxy-piperidin-1-yl)-acetic acid, 95.0%, 500mg

Ethyl 4-oxo-4H-chromene-2-carboxylate, 95.0%, 5g

1-Fluoro-3-(2-methoxyethoxy)-2-nitrobenzene, 95.0%, 5g

3-Chloro-5-methoxy-4-(3-methylbutoxy)benzoic acid, 97%, 250mg

N'-(4-Bromo-benzyl)-N,N-dimethyl-ethane-1,2-diamine, 95.0%, 500mg

(R)-1-(3-Nitrophenyl)ethanol, 97.0%, 10g